MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company ...
WPI researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict ...
Should include detailed information, to the extent practicable, on the degree of subsidization and market overcapacity by ...
New study finds that plant biodiversity collapsed in landscapes where arable production was abandoned during and after the ...
Blackstone Valley Regional Vocational Technical High School has received a grant to purchase 10 life-size rat models for its ...
MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of its ...
Spyre Therapeutics CEO Cameron Turtle talks about the search for an IBD treatment on this week's "The Readout LOUD." ...
WPI researchers use machine learning and brain scans to identify age- and sex-specific anatomical patterns that predict ...
Diffuse cutaneous systemic sclerosis (“dcSSc”) is a rare, progressive autoimmune disease characterized by immune activation, vasculopathy and fibrosis affecting the skin and internal organs, including ...
WEST LAFAYETTE, IN, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- Advancing Agricultural Excellence Through Plant ...
Experts discuss biotechnology's role in advancing personalized medicine at a VIT webinar, highlighting career opportunities ...
Anbio Biotechnology continues pivoting toward better profitability metrics, prioritized high-margin orders over sales volume.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results